Authors: Mohty, M Fegueux, N Exbrayat, C Lu, ZY Legouffe, E Quittet, P Lopez-Martinez, E Latry, P Avinens, O Hertog, C Klein, B Eliaou, JF Rossi, JF

Citation: M. Mohty et al., Enhanced graft-versus-tumor effect following dose-reduced conditioning andallogeneic transplantation for refractory lymphoid malignancies after high-dose therapy, BONE MAR TR, 28(4), 2001, pp. 335-339

Authors: Jourdan, M Tarte, K Legouffe, E Brochier, J Rossi, JF Klein, B

Citation: M. Jourdan et al., Tumor necrosis factor is a survival and proliferation factor for human myeloma cells, EUR CYTOKIN, 10(1), 1999, pp. 65-70

Authors: Costes, V Magen, V Legouffe, E Durand, L Baldet, P Rossi, JF Klein, B Brochier, J

Citation: V. Costes et al., The Mi15 monoclonal antibody (anti-Syndecan-1) is a reliable marker for quantifying plasma cells in paraffin-embedded bone marrow biopsy specimens, HUMAN PATH, 30(12), 1999, pp. 1405-1411

Authors: Tarte, K Zhang, XG Legouffe, E Hertog, C Mehtali, M Rossi, JF Klein, B

Citation: K. Tarte et al., Induced expression of B7-1 on myeloma cells following retroviral gene transfer results in tumor-specific recognition by cytotoxic T cells, J IMMUNOL, 163(1), 1999, pp. 514-524

Authors: Legouffe, E Rodriguez, C Picot, MC Richard, B Klein, B Rossi, JF Commes, T

Citation: E. Legouffe et al., C-reactive protein serum level is a valuable and simple prognostic marker in norm Hodgkin's lymphoma, LEUK LYMPH, 31(3-4), 1998, pp. 351-357